Aadi Bioscience
Aadi Bioscience appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0059-2023, Class III) was initiated on October 13, 2022.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0059-2023 | Class III | Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial | October 13, 2022 |